Table of Content

1 Anti-Migraine Drugs Market Overview
1.1 Product Overview and Scope of Anti-Migraine Drugs
1.2 Anti-Migraine Drugs Segment by Type
1.2.1 Global Anti-Migraine Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Anti-Migraine Drugs Segment by Application
1.3.1 Global Anti-Migraine Drugs Market Value by Application: (2024-2034)
1.3.2 Women
1.3.3 Men
1.4 Global Anti-Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Migraine Drugs Revenue 2018-2034
1.4.2 Global Anti-Migraine Drugs Sales 2018-2034
1.4.3 Global Anti-Migraine Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Anti-Migraine Drugs Market Competition by Manufacturers
2.1 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Migraine Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Migraine Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
2.7 Anti-Migraine Drugs Market Competitive Situation and Trends
2.7.1 Anti-Migraine Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Migraine Drugs Players Market Share by Revenue
2.7.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Migraine Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Migraine Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Anti-Migraine Drugs Global Anti-Migraine Drugs Sales by Region: 2018-2034
3.2.1 Global Anti-Migraine Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-Migraine Drugs Sales by Region: 2024-2034
3.3 Global Anti-Migraine Drugs Global Anti-Migraine Drugs Revenue by Region: 2018-2034
3.3.1 Global Anti-Migraine Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-Migraine Drugs Revenue by Region: 2024-2034
3.4 North America Anti-Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Migraine Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Anti-Migraine Drugs Sales by Country (2018-2034)
3.4.3 North America Anti-Migraine Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Migraine Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Anti-Migraine Drugs Sales by Country (2018-2034)
3.5.3 Europe Anti-Migraine Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Migraine Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Anti-Migraine Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Anti-Migraine Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Migraine Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Anti-Migraine Drugs Sales by Country (2018-2034)
3.7.3 Latin America Anti-Migraine Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Migraine Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Anti-Migraine Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Anti-Migraine Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Migraine Drugs Sales by Type (2018-2034)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-Migraine Drugs Sales by Type (2024-2034)
4.1.3 Global Anti-Migraine Drugs Sales Market Share by Type (2018-2034)
4.2 Global Anti-Migraine Drugs Revenue by Type (2018-2034)
4.2.1 Global Anti-Migraine Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-Migraine Drugs Revenue by Type (2024-2034)
4.2.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Anti-Migraine Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Anti-Migraine Drugs Sales by Application (2018-2034)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-Migraine Drugs Sales by Application (2024-2034)
5.1.3 Global Anti-Migraine Drugs Sales Market Share by Application (2018-2034)
5.2 Global Anti-Migraine Drugs Revenue by Application (2018-2034)
5.2.1 Global Anti-Migraine Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-Migraine Drugs Revenue by Application (2024-2034)
5.2.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Anti-Migraine Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly Anti-Migraine Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Anti-Migraine Drugs Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eisai Anti-Migraine Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Allergan Anti-Migraine Drugs Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Endo
6.5.1 Endo Corporation Information
6.5.2 Endo Description and Business Overview
6.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Endo Anti-Migraine Drugs Product Portfolio
6.5.5 Endo Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GlaxoSmithKline Anti-Migraine Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Impax Laboratories
6.6.1 Impax Laboratories Corporation Information
6.6.2 Impax Laboratories Description and Business Overview
6.6.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Impax Laboratories Anti-Migraine Drugs Product Portfolio
6.7.5 Impax Laboratories Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Anti-Migraine Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AstraZeneca Anti-Migraine Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bayer Anti-Migraine Drugs Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Anti-Migraine Drugs Description and Business Overview
6.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Johnson & Johnson Anti-Migraine Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Anti-Migraine Drugs Description and Business Overview
6.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Merck Anti-Migraine Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Teva
6.13.1 Teva Corporation Information
6.13.2 Teva Anti-Migraine Drugs Description and Business Overview
6.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Teva Anti-Migraine Drugs Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Corporation Information
6.14.2 Amgen Anti-Migraine Drugs Description and Business Overview
6.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Amgen Anti-Migraine Drugs Product Portfolio
6.14.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Migraine Drugs Industry Chain Analysis
7.2 Anti-Migraine Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Migraine Drugs Production Mode & Process
7.4 Anti-Migraine Drugs Sales and Marketing
7.4.1 Anti-Migraine Drugs Sales Channels
7.4.2 Anti-Migraine Drugs Distributors
7.5 Anti-Migraine Drugs Customers
8 Anti-Migraine Drugs Market Dynamics
8.1 Anti-Migraine Drugs Industry Trends
8.2 Anti-Migraine Drugs Market Drivers
8.3 Anti-Migraine Drugs Market Challenges
8.4 Anti-Migraine Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Migraine Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-Migraine Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-Migraine Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Migraine Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-Migraine Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-Migraine Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Anti-Migraine Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-Migraine Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Anti-Migraine Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Anti-Migraine Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Anti-Migraine Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-Migraine Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-Migraine Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Anti-Migraine Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Anti-Migraine Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Anti-Migraine Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-Migraine Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Anti-Migraine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Anti-Migraine Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Anti-Migraine Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-Migraine Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Anti-Migraine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Anti-Migraine Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Anti-Migraine Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-Migraine Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Anti-Migraine Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-Migraine Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-Migraine Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Anti-Migraine Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-Migraine Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Anti-Migraine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anti-Migraine Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Anti-Migraine Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-Migraine Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Anti-Migraine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Anti-Migraine Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-Migraine Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Anti-Migraine Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Anti-Migraine Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Anti-Migraine Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-Migraine Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Anti-Migraine Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-Migraine Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Anti-Migraine Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Anti-Migraine Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Anti-Migraine Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-Migraine Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2024-2034)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Eli Lilly Anti-Migraine Drugs Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Abbott Anti-Migraine Drugs Product
Table 79. Abbott Recent Developments/Updates
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Eisai Anti-Migraine Drugs Product
Table 84. Eisai Recent Developments/Updates
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Allergan Anti-Migraine Drugs Product
Table 89. Allergan Recent Developments/Updates
Table 90. Endo Corporation Information
Table 91. Endo Description and Business Overview
Table 92. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Endo Anti-Migraine Drugs Product
Table 94. Endo Recent Developments/Updates
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. GlaxoSmithKline Anti-Migraine Drugs Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Impax Laboratories Corporation Information
Table 101. Impax Laboratories Description and Business Overview
Table 102. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Impax Laboratories Anti-Migraine Drugs Product
Table 104. Impax Laboratories Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Pfizer Anti-Migraine Drugs Product
Table 109. Pfizer Recent Developments/Updates
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. AstraZeneca Anti-Migraine Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Bayer Anti-Migraine Drugs Product
Table 119. Bayer Recent Developments/Updates
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Johnson & Johnson Anti-Migraine Drugs Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Merck Anti-Migraine Drugs Product
Table 129. Merck Recent Developments/Updates
Table 130. Teva Corporation Information
Table 131. Teva Description and Business Overview
Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Teva Anti-Migraine Drugs Product
Table 134. Teva Recent Developments/Updates
Table 135. Amgen Corporation Information
Table 136. Amgen Description and Business Overview
Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. Amgen Anti-Migraine Drugs Product
Table 139. Amgen Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-Migraine Drugs Distributors List
Table 143. Anti-Migraine Drugs Customers List
Table 144. Anti-Migraine Drugs Market Trends
Table 145. Anti-Migraine Drugs Market Drivers
Table 146. Anti-Migraine Drugs Market Challenges
Table 147. Anti-Migraine Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Migraine Drugs
Figure 2. Global Anti-Migraine Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-Migraine Drugs Market Share by Type in 2024 & 2034
Figure 4. Triptans Product Picture
Figure 5. Ergots Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-Migraine Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Anti-Migraine Drugs Market Share by Application in 2024 & 2034
Figure 9. Women
Figure 10. Men
Figure 11. Global Anti-Migraine Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Anti-Migraine Drugs Market Size (2018-2034) & (US$ Million)
Figure 13. Global Anti-Migraine Drugs Sales (2018-2034) & (K Units)
Figure 14. Global Anti-Migraine Drugs Average Price (USD/Pcs) & (2018-2034)
Figure 15. Anti-Migraine Drugs Report Years Considered
Figure 16. Anti-Migraine Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Anti-Migraine Drugs Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Anti-Migraine Drugs Players: Market Share by Revenue in 2024
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Anti-Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 22. North America Anti-Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Anti-Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 26. Europe Anti-Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 27. Germany Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2018-2034)
Figure 34. China Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Anti-Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 45. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Migraine Drugs by Type (2018-2034)
Figure 55. Global Revenue Market Share of Anti-Migraine Drugs by Type (2018-2034)
Figure 56. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2018-2034)
Figure 57. Global Sales Market Share of Anti-Migraine Drugs by Application (2018-2034)
Figure 58. Global Revenue Market Share of Anti-Migraine Drugs by Application (2018-2034)
Figure 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2018-2034)
Figure 60. Anti-Migraine Drugs Value Chain
Figure 61. Anti-Migraine Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed